why Laurus Labs shares are down 15% today?
#laurus #lauruslabs #Trump #DonaldTrump 

Laurus labs posted come back results after 7 quarters and the management commentary was also good. So there is no issue with results or management commentary.

Reason for fall:

The stock is down following news reports that the US ordered a pause in foreign aid, which will cause 
a stoppage of funding for the President's Emergency Plan for AIDS Relief, or PEPFAR, as early as Monday. 

The move could also interrupt the provision of anti-viral medications (ARVs) for millions.

What is PEPFAR?
The PEPFAR program began under the George W. Bush administration and is credited  with saving millions of lives all over the world, by providing billions in funding 
to organizations to combat HIV and also provides ARVs to more than 20 million people across 55 countries, as per the report.

What Trump is doing now?
After taking office last week, President Donald Trump signed an executive order,  triggering a 90-day review of US foreign aid programs.

 A report from CBS news said that a US Agency for International Development Memo sent on Saturday explained that foreign aid pause "means a complete halt" with limited exceptions.

Please follow our telegram channel for more updates: